Nasdaq grts.
According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...
Feb 10,2023 - GRTS STOCK PRICE DECREASE: Gritstone bio Inc on 02-10-2023 decreased stock price > 10% from $3.26 to $2.90. Dec 15,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-15-2022 increased stock price > 10% from $3.11 to $3.92. Dec 14,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-14-2022 increased stock price > 10% ...(NASDAQ: GRTS) Gritstone Bio's forecast annual revenue growth rate of 76.39% is forecast to beat the US Biotechnology industry's average forecast revenue growth ...Stock analysis for Gritstone bio Inc (GRTS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...
Follow. EMERYVILLE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...
Find the latest on short interest for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.WebNov 17, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) showed a performance of -33.50% in past 30-days. Number of shares sold short was 9.12 million shares which calculate 2.48 days to cover the short interests. Wall Street analysts have assigned a consensus price target of $10.40 to the stock, which implies a rise of 86.83% to its current value.
Based on analysts offering 12 month price targets for GRTS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . EMERYVILLE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Gritstone bio, Inc. (GRTS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.3100 -0.0100 (-0.76%) As of 03:13PM EST. Market open. 1d 5d 1m 6m YTD 1y 5y 10 ต.ค. 2566 ... EMERYVILLE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims ...EMERYVILLE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...
Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Web
Dec 23, 2020 · Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its ...
EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Jul 4, 2023 · So spare a thought for the long term shareholders of Gritstone bio, Inc. (NASDAQ:GRTS); the share price is down a whopping 70% in the last three years. That might cause some serious doubts about ... EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...It is doubtless a positive to see that the Gritstone bio, Inc. ( NASDAQ:GRTS) share price has gained some 32% in the last three months. But that is small recompense for the exasperating returns ...Find the latest Insider Activity data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.
Jul 15, 2021 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Gritstone bio ( NASDAQ: GRTS) uses its vaccine technology to promote an immune response against a patients cancer or to prevent or treat infectious disease. In late September, 2023, GRTS announced ...Mar 10, 2022 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. EMERYVILLE, Calif., VANCOUVER, British Columbia, and BASEL, Switzerland, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to ...
There's no doubt that money can be made by owning shares of unprofitable businesses. Indeed, Gritstone bio (NASDAQ:GRTS) stock is up 220% in the last year, providing strong gains for shareholders.Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer ...
Financials. GRTS has a market cap of $169mn and a cash balance of $153mn. Research and development expenses were $30.5 million for the three months ended March 31, 2023 while general and ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Second Quarter 2022 Financial Results. Cash, cash equivalents, marketable securities and restricted cash were $159.2 million as of June 30, 2022, compared to $223.5 million as of December 31, 2021 ...Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio of product ...Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ปิด: 1 ธ.ค., 17 นาฬิกา 27 นาที 54 วินาที GMT-5 · USD · NASDAQ · ข้อจำกัดความรับผิด ... GRTS. $1.53. GRTS 17.69%. insightsกิจกรรมสำคัญ. กิจกรรมสำคัญจะแสดงบทความข่าว ...Find the latest news headlines from Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com.EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the …Webปิด: 1 ธ.ค., 17 นาฬิกา 27 นาที 54 วินาที GMT-5 · USD · NASDAQ · ข้อจำกัดความรับผิด ... GRTS. $1.53. GRTS 17.69%. insightsกิจกรรมสำคัญ. กิจกรรมสำคัญจะแสดงบทความข่าว ...
10 ต.ค. 2566 ... EMERYVILLE, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims ...
Gritstone Bio Inc (NASDAQ:GRTS)’s traded shares stood at 0.86 million during the last session, with the company’s beta value hitting 0.59. At the close of trading, the stock’s price was $1.88, to imply an increase of 2.73% or $0.05 in intraday trading. The GRTS share’s 52-week high remains $4.05, putting it -115.43% down since that peak ...
Dec 4, 2023 · Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has soared by 17.69 in relation to previous closing price of 1.30. Nevertheless, the company has seen a gain of 11.68% in its stock price over the last five trading days. Zacks Investment Research reported 2023-10-16 that Gritstone bio Inc. (GRTS) has been upgraded to a Zacks Rank #2 (Buy ... EMERYVILLE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Gritstone bio's $785 million collaboration for HIV therapies has quantified the value of EDGE more than any Wall Street analyst could ever do. Gilead has already given GRTS $30 million upfront and ...3. Gritstone bio, Inc. (NASDAQ:GRTS) One Week Volatility: 20.91%. Number of Hedge Fund Investors In Q2 2023: 10. Gritstone bio, Inc. (NASDAQ:GRTS) is an American healthcare company that develops ...Find the latest analyst research for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. Gritstone bio, Inc. Common Stock (GRTS) Analyst Research | Nasdaq …WebAug 15, 2022 · EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ... May 11, 2023 · First Quarter 2023 Financial Results. Cash, cash equivalents, marketable securities and restricted cash were $153.2 million as of March 31, 2023, compared to $185.2 million as of December 31, 2022 ... Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.
Find the latest Institutional Holdings data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. Nov 14, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) trade information. Sporting -3.50% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 11/13/23 when the GRTS stock price touched $1.38 or saw a rise of 25.61%. On November 8, 2023, Gritstone Bio Inc ( NASDAQ:GRTS ), a clinical-stage biotechnology company, announced its financial results for the third quarter ended September 30, 2023, along with updates ...The average trading volume of GRTS on November 15, 2023 was 2.18M shares. GRTS) stock’s latest price update. Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has gone rise by 8.72 in comparison to its previous close of 1.37, however, the company has experienced a -11.86% decrease in its stock price over the last five trading days.Instagram:https://instagram. ticker scannerbest health insurance in marylandfinancial advisor utahnasdaq hoft Financials. GRTS has a market cap of $169mn and a cash balance of $153mn. Research and development expenses were $30.5 million for the three months ended March 31, 2023 while general and ...Track Gritstone Bio Inc (GRTS) Stock Price, Quote, latest community messages, chart, news and other stock related information. a fib and alcoholtesla predictions Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. change wholesale community mortgage Oct 30, 2023 · In the last trading session, 1.12 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $1.89 changed hands at -$0.06 or -3.08% during last session, the market valuation stood at $175.92M. GRTS’s last price was a Find the latest Institutional Holdings data for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. Feb 10,2023 - GRTS STOCK PRICE DECREASE: Gritstone bio Inc on 02-10-2023 decreased stock price > 10% from $3.26 to $2.90. Dec 15,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-15-2022 increased stock price > 10% from $3.11 to $3.92. Dec 14,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-14-2022 increased stock price > 10% ...